Newpace Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Newpace General Information
Description
Manufacturer of an implantable defibrillator system designed to measure heart performance. The company's system uses implantable subcutaneous string defibrillators with monitoring capabilities that require one hour of wireless recharge in a year, enabling users to have a device in the event of sudden cardiac arrest.
Contact Information
Website
www.newpacemedical.comCorporate Office
- Granit 13, North Industrial Park
- POB 3112
- Caesarea 3088900
- Israel
Corporate Office
- Granit 13, North Industrial Park
- POB 3112
- Caesarea 3088900
- Israel
Newpace Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC | Completed | Generating Revenue | ||||
3. Grant | 31-Mar-2021 | Completed | Generating Revenue | |||
2. Grant | 16-Oct-2017 | $59.1K | $2M | Completed | Generating Revenue | |
1. Early Stage VC | 01-Aug-2015 | $2M | $2M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Newpace Patents
Newpace Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250099747-A1 | Flexible and stretchable wearable defibrillator patch | Pending | 03-Apr-2022 | ||
US-20230080043-A1 | Automated cardiac defibrillator pacer with integrated cardiac assist device | Inactive | 20-Jan-2020 | ||
US-20220355122-A1 | Automated wearable belt cardiac defibrillator | Pending | 27-Aug-2019 | ||
EP-4021566-A2 | Automated wearable belt cardiac defibrillator | Active | 27-Aug-2019 | ||
CA-3145977-A1 | Automated wearable belt cardiac defibrillator | Pending | 27-Aug-2019 | A61N1/3904 |
Newpace Signals
Newpace Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Horizon Europe | Other | |||
Horizon 2020 | Government | |||
BioStar Capital | Venture Capital | Minority | ||
Haisco Pharmaceutical Group Company | Corporation | Minority | ||
BioTelemetry | Corporation | Minority |
Newpace FAQs
-
When was Newpace founded?
Newpace was founded in 2012.
-
Where is Newpace headquartered?
Newpace is headquartered in Caesarea, Israel.
-
What is the size of Newpace?
Newpace has 10 total employees.
-
What industry is Newpace in?
Newpace’s primary industry is Monitoring Equipment.
-
Is Newpace a private or public company?
Newpace is a Private company.
-
What is Newpace’s current revenue?
The current revenue for Newpace is
. -
How much funding has Newpace raised over time?
Newpace has raised $2M.
-
Who are Newpace’s investors?
Horizon Europe, Horizon 2020, BioStar Capital, Haisco Pharmaceutical Group Company, and BioTelemetry are 5 of 6 investors who have invested in Newpace.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »